Prescription drug · NDA
Sancuso (Granisetron) NDC 66220-637
Granisetron 3.1 mg/24h · Patch · Transdermal · Cumberland Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66220-637-31 | 6622006373166220063731 | 168 h in 1 POUCH (66220-637-31)Marketed from Jul 16, 2024 | |
| 66220-637-72 | 6622006377266220063772 | 168 h in 1 POUCH (66220-637-72)Marketed from Jul 16, 2024 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sancuso
- Generic name (nonproprietary)
- granisetron
- Active ingredients
- Granisetron — 3.1 mg/24h
- Dosage form
- Patch
- Route
- Transdermal
- Labeler
- Cumberland Pharmaceuticals Inc.NDC labeler code 66220
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022198
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 3 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 66220-637_c78db5de-683f-41bd-8f25-700b9d0e2e46SPL ID c78db5de-683f-41bd-8f25-700b9d0e2e46SPL set ID 7379369a-03df-4ec3-8f2e-66645cc736d8RxCUI 825003, 825005UNII WZG3J2MCOLUPC 0066220637310
- Pharmacologic class
- Serotonin-3 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466220063731followed by a unit qualifier and the quantityPackage 66220-0637-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
SANCUSO ® is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. SANCUSO is a serotonin-3 (5-HT 3 ) receptor antagonist indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 66220-637
- What is NDC 66220-637?
- 66220-637 is the product NDC for Sancuso (granisetron), Granisetron 3.1 mg/24h patch, listed with the FDA by Cumberland Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sancuso (Granisetron).
- What is the active ingredient?
- Granisetron.
- Who is the labeler?
- Cumberland Pharmaceuticals Inc., NDC labeler code 66220. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sancuso?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.